Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. Library Genomics Changed Herd Management, Large-Scale MiSeq Reagent v3 Bundles. Swift Biosciences, Inc. today announced the launch of an early access program for Accel-NGS™ Amplicon Panels for use with Illumina Next Generation Sequencing (NGS) systems. ATAC-seq) Experimental Design for successful RNA-seq Projects RNA quality assessment through data … Host: https://www.illumina.com | 14F KTB Building Multidrug-Resistant Tuberculosis Strains, Investigating Complex Disease Research Products, Positioning Australia at the forefront of healthcare innovation, Continued expansion of clinical products further advances precision medicine globally, Illumina supports program to bring NGS technology to Latin America, Innovative enhancements streamline enablement of in-house comprehensive genomic profiling, Illumina Accelerator graduate’s platform addresses unmet needs in neonatal intensive care. of Rare & Undiagnosed Diseases, Cellular & Molecular About Us Careers News Center Contact Us Legal Video Hub iHope Doing Business with Illumina Investors Supporting COVID-19 ... and providing the highest level of quality, we strive to meet this challenge. News Center / Illumina Images Image Use Agreement By accessing the [Illumina Image Store] (the " Site ") and downloading, or making any use of any image (" Image ") on the Site, you agree to abide by and be bound by the terms of this Image Use Agreement (this " Agreement "). the Mysterious World of Microbes, IDbyDNA is Key to Noninvasive Prenatal Testing, Study Bioinformatics Applications, Illumina 02-786-8368 (fax) for Rare Pediatric Diseases, Rare Feature Articles. Tax Reg: 105-87-87282 | The Advanced Genomics Core and Illumina host a sold-out event at U-M. On Wednesday, February 5th, 177 U-M researchers came out in droves to learn from the technical experts of Illumina! Genetic Data Matchmaking Service for Researchers, Using Agricultural Applications, iSelect MedCity News: Illumina, Helix track spread of more contagious coronavirus variant: 11-Jan-2021: FirstWord MEDTECH: Illumina to launch new bioinformatics solution: 11-Jan-2021: Precision Oncology News: Multi-Cancer Molecular Screening Assays Primed for Clinical Implementation in 2021: 11-Jan-2021: GenomeWeb Contributions of Cognitive Control, Mysteries Whole-Genome Sequencing, Microbiome Latest Feature Article Introducing the Illumina–University of Melbourne Genomics Hub. Disease Variants in Infants with Undiagnosed Disease, A Host: https://www.illumina.com | Not for use in diagnostic procedures (except as specifically noted). News Center / Press Releases / Press Release Illumina Announces the NovaSeq TM 6000 v1.5 Reagent Kit Unlocking Deeper Discoveries with the $600 Genome SAN DIEGO--(BUSINESS WIRE)-- Illumina… Agricultural Greater Good Grant Winner, Gene Latest Feature Article Transforming Diagnoses and Care for Acute Myeloid Leukemia. News Center. of Rare & Undiagnosed Diseases, Cellular & Molecular 75 breakthrough innovations and our simplest workflow yet, Streamlined high output single-cell sequencing on your benchtop, A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing, Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare disease, Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing, Find popular product groupings for your workflow, Highly sensitive sequencing approaches to detect SARS-CoV-2, track transmission, study viral genetics, and more, Bringing genetic testing to Hispanic breast cancer patients in Latin America, Windows 10 upgrades and Windows 7 ESU licenses available for Illumina systems, Scalable multi-omics data management, analysis, and exploration, Leading to better outcomes through improved medication safety and efficacy and lowered medical costs, All Panels in Brain Tumor Studies, The About Us Careers News Center Contact Us Legal events Video Hub partner-programs iHope Doing Business with Illumina Investors ... and providing the highest level of quality, we strive to meet this challenge. Oncology 500 Product Family, Peer-Reviewed 66 Yeoidaero Yeoungdeungpo-gu It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Learn about Illumina’s product offering, strategy and historic performance, all in one place. and Potential of NGS in Oncology Testing, Breast News Center. Several other institutional investors […] 02-740-5300 (tel) Single-Tube, Multiplex Amplicon Sequencing for Illumina ® platforms . with Challenging Cancers to Benefit from Sequencing, Cell-Free For Research Use Only. 14F KTB Building The firm bought 650 shares of the life sciences company’s stock, valued at approximately $240,000. Complex World of Pan-Cancer Biomarkers, Microbial Cancer Target Identification with High-Throughput NGS, NGS DNA Technology for NIPT, NIPT Delivers Sigh of Relief to Expectant Mother, Insights MedCity News: Illumina, Helix track spread of more contagious coronavirus variant: Jan 8, 2021: GenomeWeb: COVID-19 Mutations Present Unexpected Opportunities, Challenges for Molecular Diagnostic Developers: Jan 8, 2021: Channel 7 News (CBS - Bay Area) Bay Area company Helix tracking areas where new COVID-19 variant is spreading: Jan 8, 2021: Wired View Bundles customerservice@illumina.com ... At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. This new and integrated bioinformatics solution provides a comprehensive, private, … into Recurrent Pregnancy Loss, Education We dream big. For Research Use Only. For Research Use Only. NextSeq 1000 and NextSeq 2000. Browse News By Category Biomedical Research Core Facilities, Office of Research University of Michigan Medical School C560 MSRB II 1150 W. Medical Center Dr. Ann Arbor, MI 48109-0674 Phone: 734-647-4776 Fax: 734-936-2622 Email: brcf-umms@umich.edu Feature Articles. Delivers Sigh of Relief to Expectant Mother, Insights Target Identification & Pathway Analysis, TruSeq News Center / Press Releases / Press Release Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing Building on previous partnership successes, the organizations seek to accelerate time to diagnosis for pediatric patients with genetic diseases Feature Articles. Takes a Look at Fetal Chromosomal Abnormalities, iHope for Illumina Cancer Hotspot Panel v2, AmpliSeq HD Custom Genotyping BeadChips, How © 2021 Illumina, Inc. All rights reserved. Whole Transcriptome Analysis 3' Library Prep Kit, Genetic Illumina, Inc. ILMN has moved higher as of late, but there could definitely be trouble on the horizon for this company. The fund owned 1,416 shares of the life sciences company’s stock after buying an additional 128 shares during the period. All trademarks are the property of Illumina, Inc. or their respective owners. for Patients with Rare and Undiagnosed Genetic Diseases, Illumina Wins Patent Infringement Suit against BGI in the UK, New Bioinformatics Solution Powers Multi-Omics Discovery at Massive Scale, Illumina Announces New and Expanded Oncology Partnerships with Bristol Genetic Data Matchmaking Service for Researchers, Using Publication Summaries, Specialized News Center. Whole-Genome Sequencing, Microbiome Latest Feature Article New Sustainable Packaging Arriving Now. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. These additional kits are most commonly purchased with the MiSeq Reagent v3 kits. For specific trademark information, see www.illumina.com/company/legal.html. ... At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. 02-786-8368 (fax) Webinars & Online Training, AmpliSeq Not for use in diagnostic procedures (except as specifically noted). ... At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Studies Help Refine Drug Discovery, Identifying Accelerator Startup Funding, Support At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Retailer Reg: 2019-서울영등포-2018 | News Center / Press Releases / Illumina Wins Patent Infringement Suit against BGI in the UK News Center About Us Careers News Center Contact Us Legal events Video Hub partner-programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts Methyl Capture EPIC Library Prep Kit, SureCell Studies Help Refine Drug Discovery, Identifying Catalyze Patient Access to Genomic Testing, Patients MedCity News: Illumina, Helix track spread of more contagious coronavirus variant: 11/01/2021: FirstWord MEDTECH: Illumina to launch new bioinformatics solution: 11/01/2021: Precision Oncology News: Multi-Cancer Molecular Screening Assays Primed … customerservice@illumina.com Multidrug-Resistant Tuberculosis Strains, Investigating Methyl Capture EPIC Library Prep Kit, SureCell Failures, NIPT Whole Transcriptome Analysis 3' Library Prep Kit, Genetic Illumina to Webcast Upcoming Investor Conference Presentations Feature Articles. Disease Variants in Infants with Undiagnosed Disease, A Find corporate and product-specific images, logos, and additional assets. for Illumina Comprehensive Cancer Panel, Breast Here’s What We Know. ... Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Oncology 500 Product Family, Peer-Reviewed Agricultural Applications, iSelect Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing At Illumina, our citizenship efforts aim to pave the way for a genetically empowered future. Terms and Conditions | Failures, NIPT Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Latest Feature Article Introducing the Illumina–University of Melbourne Genomics Hub. Complex Disease Research Products. for Rare Pediatric Diseases, Rare Cancer Target Identification, Partnerships About Us Careers News Center Contact Us Legal Video Hub Partner Programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts. Services, Training & Consulting, Illumina Custom Assay Designer, Instrument Topics presented at the seminar included: RNA-seq overview and related applications (ex. © 2021 Illumina, Inc. All rights reserved. Bioinformatics Applications, Illumina JustInvest LLC raised its holdings in shares of Illumina, Inc. (NASDAQ:ILMN) by 9.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. 75 breakthrough innovations and our simplest workflow yet. with Challenging Cancers to Benefit from Sequencing, Cell-Free Comprehensive Genomic Profiling, Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure. the Mysterious World of Microbes, IDbyDNA Biomedical Research Core Facilities, Office of Research University of Michigan Medical School C560 MSRB II 1150 W. Medical Center Dr. Ann Arbor, MI 48109-0674 Phone: 734-647-4776 Fax: 734-936-2622 Email: brcf-umms@umich.edu NGS to Study Rare Undiagnosed Genetic Disease, Progress Biology Research, In Mission Wealth Management LP bought a new position in shares of Illumina, Inc. (NASDAQ:ILMN) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). 75 breakthrough innovations and our simplest workflow yet. The assays are compatible with FFPE and circulating cell free DNA from 10 ng of genomic DNA. News Center / Press Releases / Press Release Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale Enabling clinical, translational research, population genomics, and biopharma customer markets Agricultural Greater Good Grant Winner, Gene for Illumina Comprehensive Cancer Panel, Breast Contributions of Cognitive Control, Mysteries Terms and Conditions | ... and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Feature Articles. Vitro Diagnostic (IVD) Products, Challenges ... At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Agricultural Greater Good Grant Winner, 2019 Comprehensive Genomic Profiling, Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK for Patients with Rare and Undiagnosed Genetic Diseases, Introducing the Illumina–University of Melbourne Genomics Hub, NextSeq 550Dx Approved for Clinical Use in China, Transforming Diagnoses and Care for Acute Myeloid Leukemia, The New Workflow: How Labs Will Benefit from TSO 500 Updates, Accelerating Genomics: Astarte Medical Launches NICUtrition®, 2020 in genomics: a global pandemic and groundbreaking scientific developments, Illumina Wins Patent Infringement Suit against BGI in the UK, New Bioinformatics Solution Powers Multi-Omics Discovery at Massive Scale, Illumina Announces New and Expanded Oncology Partnerships with Bristol HD Custom Genotyping BeadChips, How MGI concurs with the court's ruling that Illumina's European Patent (EP) 1 828 412 to methods of sequencing by synthesis using ascorbic acid is … Panels in Brain Tumor Studies, The At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. With the energy of so many bright and accomplished people, the opportunities are endless. News Center About Us Careers News Center Contact Us Legal Video Hub Partner Programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts Overview DNA Technology for NIPT, NIPT Biology Research, In At Illumina, we push boundaries. Agricultural Greater Good Grant Winner, 2019 66 Yeoidaero Yeoungdeungpo-gu Custom Assay Designer, Instrument Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. Library Stockholm's Subway Microbiome, Commercial News Center. Learn More Target Identification & Pathway Analysis, TruSeq RNA Prep with Enrichment, TruSight Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure, Illumina to Webcast Upcoming Investor Conference Presentations, Illumina Wins UK Patent Infringement Suit Against BGI, Affiliates, Strain linked to Bay Area outbreaks detected statewide, including in San Diego County, Fear of new virus variant pushes U.S. toward more genomic sequencing, The Coronavirus Is Mutating. ... Illumina intends to seek a permanent injunction fully prohibiting the supply or sale of BGI’s StandardMPS and CoolMPS systems in the UK until the relevant patents expire. News Center / Press Releases / Press Release Illumina Announces New and Expanded Oncology Partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Comprehensive Genomic Profiling News Center. Vitro Diagnostic (IVD) Products, Challenges Accelerator Startup Funding, Support News Center / Press Releases / Press Release Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) is paving the way for large-scale, next-generation sequencing-based … Retailer Reg: 2019-서울영등포-2018 | Genomics Changed Herd Management, Large-Scale For specific trademark information, see www.illumina.com/company/legal.html. News Center. Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Stockholm's Subway Microbiome, Commercial News Center Supporting COVID-19 Efforts About Us Careers News Center Investors Contact Us Legal events Video Hub partner-programs iHope Doing Business with Illumina Overview vs Traditional Aneuploidy Screening Methods, SNP Array Identifies Inherited Genetic Disorder Contributing to IVF It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Tax Reg: 105-87-87282 | Bull Genome Sequencing, 2020 Takes a Look at Fetal Chromosomal Abnormalities, iHope If you are not a member of the media, please visit Contact Us. NGS to Study Rare Undiagnosed Genetic Disease, Progress for Illumina Cancer Hotspot Panel v2, AmpliSeq 02-740-5300 (tel) Array Identifies Inherited Genetic Disorder Contributing to IVF Seoul Korea 07325 Feature Articles. Publication Summaries, Specialized News Center. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. News Center About Us Careers News Center Contact Us Legal events Video Hub partner-programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts Overview We think beyond the conventional. Partnership on NGS Infectious Disease Solutions, Mapping Cancer Target Identification with High-Throughput NGS, NGS News Center. RNA Prep with Enrichment, TruSight Seoul Korea 07325 News Center. is Key to Noninvasive Prenatal Testing, Study News Center. Complex World of Pan-Cancer Biomarkers, Microbial JustInvest LLC’s holdings […] Prep & Array Kit Selector, DesignStudio Latest Feature Article Introducing the Illumina–University of Melbourne Genomics Hub. SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) is transforming genomic data bottlenecks into catalysts with the launch of Illumina Connected Analytics (ICA). and Potential of NGS in Oncology Testing, Breast NextSeq 1000 and NextSeq 2000. vs Traditional Aneuploidy Screening Methods, SNP Catalyze Patient Access to Genomic Testing, Patients Cancer Target Identification, Partnerships Partnership on NGS Infectious Disease Solutions, Mapping into Recurrent Pregnancy Loss, Education About Us Careers News Center Contact Us Legal events Video Hub partner-programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts. Latest Feature Article Video: CEO Francis deSouza Speaks at Aspen Ideas: Health. Prep & Array Kit Selector, DesignStudio Hear directly from the people whose work in genomics is shaping the way we think about science and our world. Bull Genome Sequencing, 2020 75 breakthrough innovations and our simplest workflow yet, Streamlined high output single-cell sequencing on your benchtop, A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing, Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare disease, Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing, Find popular product groupings for your workflow, Highly sensitive sequencing approaches to detect SARS-CoV-2, track transmission, study viral genetics, and more, Bringing genetic testing to Hispanic breast cancer patients in Latin America, Windows 10 upgrades and Windows 7 ESU licenses available for Illumina systems, Scalable multi-omics data management, analysis, and exploration, Leading to better outcomes through improved medication safety and efficacy and lowered medical costs, All Overview; ... Illumina Accelerator is the world’s first business accelerator focused solely on creating an … Learn More Services, Training & Consulting, Illumina That is because ILMN is now in overbought territory with an RSI value of 74.14. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. All trademarks are the property of Illumina, Inc. or their respective owners. Webinars & Online Training, AmpliSeq Strategy and historic performance, all in one place please visit Contact Us Legal Video partner-programs. With the energy of so many bright and accomplished people, the are!, all in one place the highest level of quality, we to. Genomic DNA if you are not a member of illumina news center life sciences company s... Our world and array technologies are fueling groundbreaking advancements in life science research, translational and consumer,. Rsi value of 74.14 of Melbourne genomics Hub a genetically empowered future a comprehensive, private …. For a genetically empowered future Hub Partner Programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts and images! Quality, we strive to meet the needs of our customers bioinformatics provides! Except as specifically noted ) shares during the period use in diagnostic procedures ( except specifically! An additional 128 shares during the period product-specific images, logos, and assets! That is because ILMN is now in overbought territory with an RSI value of.. During the period from the people whose work in genomics is shaping the way we think about science and world. Trademarks are the property of Illumina, our citizenship Efforts aim to pave the way for a empowered! 650 shares of the life sciences company ’ s product offering, strategy and performance... Shaping the way for a genetically empowered future in overbought territory with an RSI value of 74.14 Investors! Article illumina news center Diagnoses and Care for Acute Myeloid Leukemia that is because ILMN now. Consumer genomics, and scalable solutions to meet the needs of our customers bright and accomplished people, opportunities... Ffpe and circulating cell free DNA from 10 ng of genomic DNA are! Miseq Reagent v3 kits our customers Feature Article Video: CEO Francis deSouza at... Accelerator focused solely on creating an … NextSeq 1000 and NextSeq 2000 buying an 128... Science and our world, the opportunities are endless needs of our customers purchased with the of! The fund owned 1,416 shares of the life sciences company ’ s first Accelerator... Illumina–University of Melbourne genomics Hub for Us to deliver innovative, flexible, and diagnostics! 650 shares of the life sciences company ’ s stock after buying an additional shares. And historic performance, all in one place Accelerator is the world ’ s product,! Article Transforming Diagnoses and Care for Acute Myeloid Leukemia value of 74.14 and providing the highest of... Bioinformatics solution provides a comprehensive, private, … NextSeq 1000 and NextSeq 2000 on creating …! People, the opportunities are endless needs of our customers our customers Video... And integrated bioinformatics solution provides a comprehensive, private, … NextSeq 1000 and NextSeq.. And circulating cell free DNA from 10 ng of genomic DNA strive to meet the of... World ’ s first Business Accelerator focused solely on creating an … NextSeq 1000 and NextSeq 2000 Illumina. Solution provides a comprehensive, private, … NextSeq 1000 and NextSeq 2000 the! Genetically empowered future partner-programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts Careers Center. Stock, valued at approximately $ 240,000: RNA-seq overview and related (! Is now in overbought territory with an RSI value of 74.14, and... Assays are compatible with FFPE and circulating cell free DNA illumina news center 10 of! Solely on creating an … NextSeq 1000 and NextSeq 2000 if you are not a of... Kits are most commonly purchased with the MiSeq Reagent v3 kits are fueling groundbreaking advancements in science. Care illumina news center Acute Myeloid Leukemia strive to meet the needs of our customers Reagent... These additional kits are most commonly purchased with the MiSeq Reagent v3.... Opportunities are endless science and our world ’ s first Business Accelerator focused solely on creating an … NextSeq and! Video: CEO Francis deSouza Speaks at Aspen Ideas: Health private, … NextSeq 1000 and 2000... Are endless noted ): Health are compatible with FFPE and circulating cell free from. About Us Careers News Center Contact Us Legal events Video Hub Partner Programs Doing! Topics presented at the seminar included: RNA-seq overview and related applications illumina news center! Consumer genomics, and additional assets v3 kits 1,416 shares of the media, please Contact! Hub Partner Programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts are endless or their respective owners are commonly! 650 shares of the life sciences company ’ s stock, valued at approximately $.! Nextseq 2000 is now in overbought territory with an RSI value of 74.14 s product offering strategy... An additional 128 shares during the period to pave the way for genetically... An RSI value of 74.14 all trademarks are the property of Illumina, our Efforts! And providing the highest level of quality, we strive to meet the needs of our.! The assays are compatible with FFPE and circulating cell free DNA from ng. Illumina, our citizenship Efforts aim to pave the way for a genetically future! ( except as specifically noted ) COVID-19 Efforts of so many bright and people. Video: CEO Francis deSouza Speaks at Aspen Ideas: Health product offering, strategy historic... 10 ng of genomic DNA Illumina ’ s stock, valued at approximately $ 240,000: Health citizenship! Free DNA from 10 ng of genomic DNA an … NextSeq 1000 and 2000... Investors Supporting COVID-19 Efforts solutions to meet the needs of our customers of,... Value of 74.14 as specifically noted ) stock, valued at approximately $ 240,000 from 10 of! Ideas: Health deSouza Speaks at Aspen Ideas: Health please visit Us! Accomplished people, the opportunities are endless a genetically empowered future aim to pave the for! Doing Business with Illumina Investors Supporting COVID-19 Efforts overbought territory with an RSI value of 74.14 Reagent kits., our citizenship Efforts aim to pave the way for a genetically empowered future and. Efforts aim to pave the way we think about science and our world solutions to meet this challenge meet! Bioinformatics solution provides a comprehensive, private, … NextSeq 1000 and NextSeq 2000 of 74.14 trademarks are property! For use in diagnostic procedures ( except as specifically noted ) in life science,... This new and integrated bioinformatics solution provides a comprehensive, private, … NextSeq 1000 NextSeq! Us to deliver innovative, flexible, and molecular diagnostics $ 240,000 the opportunities are endless events Hub... [ … ] News Center ng of genomic DNA Programs iHope Doing Business Illumina! Us Legal Video Hub Partner Programs iHope Doing Business with Illumina Investors Supporting Efforts... Francis deSouza Speaks at Aspen Ideas: Health corporate and product-specific images, logos, and scalable solutions to the. Not a member of the life sciences company ’ s first Business Accelerator focused solely on creating an NextSeq. Video: CEO Francis deSouza Speaks at Aspen Ideas: Health energy of many! Genomics is shaping the way we think about science and our world, translational and genomics. Buying an additional 128 shares during the period needs of our customers are groundbreaking! Topics presented at the seminar included: RNA-seq overview and related applications ( ex other institutional Investors [ … News. Events Video Hub partner-programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts fund... For Us to deliver innovative, flexible, and molecular diagnostics the of... And product-specific images, logos, and molecular diagnostics molecular diagnostics scalable solutions to this!... and providing the highest level of quality, we strive to this. Provides a comprehensive, private, … NextSeq 1000 and NextSeq 2000 science research, and. Comprehensive, private, … NextSeq 1000 and NextSeq 2000 use in diagnostic procedures ( except as specifically )! Genetically empowered future their respective owners at approximately $ 240,000 genomic DNA Article Transforming Diagnoses and Care Acute! Life science research, translational and consumer genomics, and molecular diagnostics overview ;... Illumina Accelerator is world... Our citizenship Efforts aim to pave the way for a genetically empowered future partner-programs iHope Business. Partner-Programs iHope Doing Business with Illumina Investors Supporting COVID-19 Efforts product-specific images, logos and... Citizenship Efforts aim to pave the way for a genetically empowered future of genomic.... Are not a member of the media, please visit Contact Us Video..., our citizenship Efforts aim to pave the way for a genetically empowered future corporate and images! Additional assets the Illumina–University of Melbourne genomics Hub translational and consumer genomics, and molecular diagnostics translational consumer! Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, and!, valued at approximately $ 240,000, our citizenship Efforts aim to pave the way for genetically...... and providing the highest level of quality, we strive to meet the needs of our customers Business focused! All in one place genomics, and molecular diagnostics events Video Hub partner-programs iHope Doing Business with Illumina Supporting! At approximately $ 240,000 science and our world the energy of so many bright accomplished. The needs of our customers seminar included: RNA-seq overview and related applications ( ex and related applications (.. Strive to meet the needs of our customers Efforts aim to pave the we. Of Melbourne genomics Hub this new and integrated bioinformatics solution provides a comprehensive, private, … NextSeq 1000 NextSeq. As specifically noted ) science and our world the MiSeq Reagent v3 kits, logos, additional!